Skip to content

Assessment of 3D Angular Arm Velocity During Elevation in People With Subacromial Pain Syndrome Pre-post Rehabilitation: a Pilot Study

Assessment of 3D Angular Arm Velocity During Elevation in People With Subacromial Pain Syndrome Pre-post Rehabilitation: a Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07635550
Acronym
CoiFFaX
Enrollment
13
Registered
2026-06-09
Start date
2025-03-01
Completion date
2025-07-30
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subacromial Pain Syndrome

Keywords

shoulder, subacromial pain syndrome, inertial measurement unit, velocity, rehabilitation

Brief summary

Clinicians need accurate, simple and interpretable indicators to evaluate shoulder 3 performance, including movement speed. The primary objective was to assess the changes in mean 4 angular velocity norm and velocity variation measured by an innovative score, after rehabilitation. The 5 secondary objective was to assess the relationship between changes in both velocity variables and in 6 shoulder pain and activity limitation.

Detailed description

Current clinical assessment of shoulder pain focus on range of motion (RoM), clinical tests and disability, but lack information on shoulder performance. Shoulder performance is an imprecise multidimensional concept including RoM, accuracy, smoothness, and velocity. Clinicians need simple and accurate methods to measure shoulder performance. Rotator cuff lesions are the most common shoulder pathologies. These pathologies include a wide range of soft-tissue conditions surrounding the humeral head that are grouped under the term subacromial pain syndrome (SPS). SPS is associated with pain, decreased active shoulder elevation, activity limitation and decreased quality of life. Physiotherapy is the first-line treatment for chronic SPS for pain and function. Inertial measurement units (IMUs) have been used to assess velocity variables in people with SPS. The intra- and inter-observer reliability of kinematic temporal variables measured using IMUs is excellent in people with shoulder disorders. Most studies assessed functional arm activities rather than analytic arm elevation movements that are typically evaluated in clinical practice. Furthermore, they used rather complex kinematic temporal parameters (cumulative velocity distribution, power, moment or asymmetry scores) that can lack interpretability for clinicians. We wanted to employ accurate and clinically meaningful velocity variables used to assess arm movements during standard clinical shoulder examinations.

Interventions

OTHERAssessment of 3D angular arm velocity during elevation

Assessment of 3D angular arm velocity during elevation

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥18 years, 2. unilateral SPS diagnosed by a physician using clinical tests and imaging, 3. enrolled in a usual care 4-session rehabilitation program in the PMR outpatient department.

Exclusion criteria

1. shoulder fracture or dislocation or shoulder surgery (with implant) \<1 year previously, 2. SLAP lesion, 3. neurological pathology, 4. cervico-brachial neuralgia.

Design outcomes

Primary

MeasureTime frameDescription
Mean angular velocity norm in degrees per secondDay 0The angular velocity norm provides a measure of velocity during arm elevation, taking into account the 3 movement axes and not only the main movement axis.
Velocity variation during movement timeDay 0By normalizing the cumulative velocity change by the highest frame-to-frame variation, this metric captures the overall irregularity of motion.

Secondary

MeasureTime frameDescription
Numeric Rating ScaleDay 0Pain intensity assessed on a Numeric Rating Scale (NRS, 0-100, 0: no pain, 100: maximum pain imaginable)
Quick DASH QuestionnaireDay 0Measurement of disability and symptoms of musculoskeletal disorders related to upper limb impairment (DASH self-report questionnaire; 30 = no functional impairment to 150 = maximum impairment)
SPADI self-administered questionnaireDay 0Pain and disability (SPADI self-administered questionnaire), pain subscore (0: no pain, 50: maximum imaginable pain) and disability subscore (0: no disability, 80: maximum signs of disability).
FABQ self-administered questionnaire on shoulder painDay 0Misconceptions and apprehension regarding physical activities and work (FABQ-Shoulder self-report questionnaire), physical activities subscore (questions 2, 3, 4, 5: 0 = no apprehension/misconceptions, 24 = maximum signs of apprehension/misconceptions) and work subscore (questions 6, 7, 9, 10, 11, 12, 15: 0 = no apprehension/misconceptions, 42 = maximum signs of apprehension/misconceptions)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026